NEWCASTLE DISEASE

More documents

Recommendations

Info

Log 10 titre Immunity to turkeys RDVF Vs D58 Vs LaSOTA - HI 2.500 2.000 1.500 1.000 0.500 0.000 -0.500 1 2 3 4 5 6 7 8 9 10 11 12 Age in w eeks RDVF+LaSOTA D58+LaSOTA LaSota+LaSota
Log 10 Titre Immunity to turkeys 6.600 6.400 6.200 6.000 5.800 5.600 5.400 5.200 5.000 4.800 4.600 4.400 4.200 4.000 3.800 3.600 3.400 3.200 3.000 2.800 2.600 2.400 2.200 2.000 1.800 1.600 1.400 1.200 1.000 0.800 0.600 0.400 0.200 0.000 -0.200 -0.400 1 2 3 4 5 6 7 8 9 10 11 12 Age in w eeks D58+La D58 No Vacc D58+La D58 No. Vacc
Page 1 and 2: THERMOSTABLE VACCINE AGAINST NEWCAS
Page 3 and 4: Stages in development • Carried o
Page 5 and 6: Stage 2 - Thermostabilization • T
Page 7 and 8: Stage 2 - Thermostabilization • C
Page 9 and 10: Stage 3 - Production & Standardizat
Page 11 and 12: Log HI titre Stage 5 - Post vaccina
Page 13 and 14: Stage 5 - Post vaccination trials (
Page 19 and 20: Mean OD Values Stage 5 - Post vacci
Page 21 and 22: Stage 5 - Genetic characterization
Page 27 and 28: Stage 6 - Field trials • Use of v
Page 29 and 30: Trial 1 Stage 6 - Field trials (Ind
Page 35 and 36: Trial-II Farm A Stage 6 - Field tri
Page 37 and 38: Stage 7 - Transfer of Technology
Page 39: Log 10 titre Immunity to turkeys RD
Page 43 and 44: Standardization of Vaccine • Foll
Page 45 and 46: Log titre Log2 Titre LOG titre Stag
Page 47 and 48: Post vaccination trials (field) •
Page 49 and 50: Summary • Developed a theromostab
Page 51: Acknowledgements • To the Tamil N

NEWCASTLE DISEASE

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?